ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS


Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Biocryst Pharmaceuticals (BCRX) Reports Second Quarter 2014 Financial Results 8/5/2014 7:56:35 AM
Biocryst Pharmaceuticals (BCRX) To Announce Second Quarter 2014 Financial Results August 5 7/22/2014 3:22:34 PM
Biocryst Pharmaceuticals (BCRX) Announces Exercise Of Over-Allotment Option And Completion Of Public Offering 6/3/2014 10:52:18 AM
Biocryst Pharmaceuticals (BCRX) Prices Public Offering Of Common Stock 5/29/2014 9:07:57 AM
Biocryst Pharmaceuticals (BCRX) Commences Public Offering Of Common Stock 5/28/2014 9:03:16 AM
Biocryst Pharmaceuticals (BCRX) Announces Positive Results From Opus-1, A Phase 2 Trial Of BCX4161 For The Prophylactic Treatment Of Hereditary Angioedema 5/27/2014 9:03:06 AM
Biocryst Pharmaceuticals (BCRX) To Announce Results From The BCX4161 Opus-1 Phase 2 Trial For Hereditary Angioedema May 27 5/27/2014 8:57:14 AM
Biocryst Pharmaceuticals (BCRX) To Present At Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference 5/9/2014 9:52:02 AM
Biocryst Pharmaceuticals (BCRX) Reports First Quarter 2014 Financial Results 5/8/2014 9:32:40 AM
12345678910...